What's New

Lash & Goldberg LLP defended a shareholder derivative action on behalf of a director in a wireless cellular telephone company.

Lash & Goldberg LLP and its co-counsel obtained a dismissal in federal court, with prejudice, of an employee’s complaint to recover benefits under the Employee Retirement Income Security Act (ERISA) against a telecommunications company and its in-house counsel. The employee previously had asserted similar claims in a separate lawsuit and had released those claims as part of a negotiated settlement of that lawsuit.

Lash & Goldberg LLP defended a physician services company in arbitration before a retired state trial and appellate court judge against a physician’s $2 million breach of contract claim.  The company had terminated the physician’s employment agreement on the grounds that he had breached his representations and warranties regarding the existence of a restrictive covenant with his former employer.

Lash & Goldberg LLP served as co-counsel for its named plaintiff client in this federal antitrust class action against Bristol-Myers alleging the unlawful monopolization of the national market for paclitaxel, a cancer drug sold under the brand name Taxol.

Lash & Goldberg LLP represented several South Florida hospitals of a national health system against Beech Street, a national brokered preferred provider organization.  The hospitals contended that Beech Street improperly allowed fraudulent and unlicensed payers to access the preferred provider network, exposing the hospitals to claims for medical services that could not, and would not, be paid by the fraudulent entities.